FIG 1.
Patient enrollment and disposition. Data cutoff, November 10, 2021. aSome patients had multiple reasons given for study discontinuation. AE, adverse event; Gilt, gilteritinib; QD, once daily; Ven, venetoclax.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.